Role of copper in regression of cardiac hypertrophy

Ahmed, 1999, Stabilization of fibronectin mats with micromolar concentrations of copper, Biomaterials, 20, 201, 10.1016/S0142-9612(98)00015-5 Albin, 1973, Synthesis and degradation of mitochondrial components in hypertrophied rat heart, Biochem J, 136, 629, 10.1042/bj1360629 Alessandri, 1984, Angiogenesis in vivo and selective mobilization of capillary endothelium in vitro by heparin–copper complex, Microcirc Endothel Lymphat, 1, 329 Antos, 2002, Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo, Proc Natl Acad Sci, 99, 907, 10.1073/pnas.231619298 Apostolova, 2003, Copper–homocysteine complexes and potential physiological actions, J Inorg Biochem, 95, 321, 10.1016/S0162-0134(03)00133-8 Arany, 2008, HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha, Nature, 451, 1008, 10.1038/nature06613 Arany, 1996, An essential role for p300/CBP in the cellular response to hypoxia, Proc Natl Acad Sci U S A, 93, 12969, 10.1073/pnas.93.23.12969 Arroyo, 2010, Extracellular matrix, inflammation, and the angiogenic response, Cardiovasc Res, 86, 226, 10.1093/cvr/cvq049 Ashino, 2010, Unexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migration, Circ Res, 107, 787, 10.1161/CIRCRESAHA.110.225334 Augustin, 2009, Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system, Nat Rev Mol Cell Biol, 10, 165, 10.1038/nrm2639 Banerjee, 2008, VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1–VEGFR1–PI3K axis, Biochemistry, 47, 3345, 10.1021/bi8000352 Bartling, 1999, Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure, Circulation, 100, II216, 10.1161/01.CIR.100.suppl_2.II-216 Bartnikas, 2001, How to make a metalloprotein, Nat Struct Biol, 8, 733, 10.1038/nsb0901-733 Battegay, 1994, PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors, J Cell Biol, 125, 917, 10.1083/jcb.125.4.917 Beers, 1997, Purification, characterization, and localization of yeast Cox17p, a mitochondrial copper shuttle, J Biol Chem, 272, 33191, 10.1074/jbc.272.52.33191 Bentley, 2009, Tipping the balance: robustness of tip cell selection, migration and fusion in angiogenesis, PLoS Comput Biol, 5, e1000549, 10.1371/journal.pcbi.1000549 Berra, 2000, MAP kinases and hypoxia in the control of VEGF expression, Cancer Metastasis Rev, 19, 139, 10.1023/A:1026506011458 Bode, 1992, Mitochondrial respiration in heart, liver, and kidney of copper-deficient rats, J Nutr Biochem, 3, 668, 10.1016/0955-2863(92)90088-Z Boluyt, 1997, Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase, Circ Res, 81, 176, 10.1161/01.RES.81.2.176 Brem, 2005, Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma, Neuro Oncol, 7, 246, 10.1215/S1152851704000869 Brem, 1990, Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor, Am J Pathol, 137, 1121 Brewer, 2005, Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer, Curr Cancer Drug Targets, 5, 195, 10.2174/1568009053765807 Brewer, 2000, Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study, Clin Cancer Res, 6, 1 Brilla, 1994, Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure, Eur Heart J, 15, 45, 10.1093/eurheartj/15.suppl_D.45 Buchwald, 1990, Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy, Eur Heart J, 11, 509, 10.1093/oxfordjournals.eurheartj.a059743 Bugger, 2010, Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure, Cardiovasc Res, 85, 376, 10.1093/cvr/cvp344 Calhoun, 1994, The cytochrome oxidase superfamily of redox-driven proton pumps, Trends Biochem Sci, 19, 325, 10.1016/0968-0004(94)90071-X Cantley, 2002, The phosphoinositide 3-kinase pathway, Science, 296, 1655, 10.1126/science.296.5573.1655 Carmeliet, 2000, Mechanisms of angiogenesis and arteriogenesis, Nat Med, 6, 389, 10.1038/74651 Carmeliet, 1998, Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis, Nature, 394, 485, 10.1038/28867 Carmeliet, 1996, Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele, Nature, 380, 435, 10.1038/380435a0 Carmeliet, 1999, Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188, Nat Med, 5, 495, 10.1038/8379 Carr, 2002, Yeast Cox11, a protein essential for cytochrome c oxidase assembly, is a Cu(I)-binding protein, J Biol Chem, 277, 31237, 10.1074/jbc.M204854200 Carr, 2003, Assembly of cytochrome c oxidase within the mitochondrion, Acc Chem Res, 36, 309, 10.1021/ar0200807 Carrasco-Pozo, 2006, In vitro interaction between homocysteine and copper ions: potential redox implications, Exp Biol Med (Maywood), 231, 1569, 10.1177/153537020623100918 Chao, 1994, Low levels of ATP synthase and cytochrome c oxidase subunit peptide from hearts of copper-deficient rats are not altered by the administration of dimethyl sulfoxide, J Nutr, 124, 789, 10.1093/jn/124.6.789 Chappell, 2010, Vascular development: genetic mechanisms and links to vascular disease, Curr Top Dev Biol, 90, 43, 10.1016/S0070-2153(10)90002-1 Chen, 2002, Impaired cardiac mitochondrial membrane potential and respiration in copper-deficient rats, J Bioenerg Biomembr, 34, 397, 10.1023/A:1021258204921 Chipperfield, 1978, Differences in metal content of the heart muscle in death from ischemic heart disease, Am Heart J, 95, 732, 10.1016/0002-8703(78)90503-3 Cobine, 2006, Copper trafficking to the mitochondrion and assembly of copper metalloenzymes, Biochim Biophys Acta Mol Cell Res, 1763, 759, 10.1016/j.bbamcr.2006.03.002 Conway, 2001, Molecular mechanisms of blood vessel growth, Cardiovasc Res, 49, 507, 10.1016/S0008-6363(00)00281-9 Cooper, 2004, Regeneration of the heart in diabetes by selective copper chelation, Diabetes, 53, 2501, 10.2337/diabetes.53.9.2501 Cooper, 2009, A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study, Diabetologia, 52, 715, 10.1007/s00125-009-1265-3 Coulson, 1963, Cardiovascular studies on copper-deficient swine. V. The histogenesis of the coronary artery lesions, Am J Pathol, 43, 945 Cross, 2001, FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition, Trends Pharmacol Sci, 22, 201, 10.1016/S0165-6147(00)01676-X Culotta, 1997, The copper chaperone for superoxide dismutase, J Biol Chem, 272, 23469, 10.1074/jbc.272.38.23469 Dai, 2012, Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress, Cardiovasc Res, 93, 79, 10.1093/cvr/cvr274 Dallman, 1967, Cytochrome oxidase repair during treatment of copper deficiency: relation to mitochondrial turnover, J Clin Invest, 46, 1819, 10.1172/JCI105672 Davidson, 1992, Cardiac ultrastructural and electrophysiological abnormalities in postweanling copper-restricted and copper-repleted rats in the absence of hypertrophy, J Nutr, 122, 1566, 10.1093/jn/122.7.1566 De Freitas, 2003, Yeast, a model organism for iron and copper metabolism studies, Biometals, 16, 185, 10.1023/A:1020771000746 De Smet, 2009, Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way, Arterioscler Thromb Vasc Biol, 29, 639, 10.1161/ATVBAHA.109.185165 DeBosch, 2006, Akt1 is required for physiological cardiac growth, Circulation, 113, 2097, 10.1161/CIRCULATIONAHA.105.595231 Diez, 2001, Clinical aspects of hypertensive myocardial fibrosis, Curr Opin Cardiol, 16, 328, 10.1097/00001573-200111000-00003 Distler, 2004, Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis, Circ Res, 95, 109, 10.1161/01.RES.0000134644.89917.96 Dobaczewski, 2011, Transforming growth factor (TGF)-beta signaling in cardiac remodeling, J Mol Cell Cardiol, 51, 600, 10.1016/j.yjmcc.2010.10.033 Dong, 2013, Disturbance of copper homeostasis is a mechanism for homocysteine-induced vascular endothelial cell injury, PLoS ONE, 8, e76209, 10.1371/journal.pone.0076209 Dorn, 2005, Protein kinase cascades in the regulation of cardiac hypertrophy, J Clin Invest, 115, 527, 10.1172/JCI24178 Dudman, 1983, Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency, Clin Chim Acta, 127, 105, 10.1016/0009-8981(83)90080-3 Dumont, 1998, Cardiovascular failure in mouse embryos deficient in VEGF receptor-3, Science, 282, 946, 10.1126/science.282.5390.946 Eckardt, 2003, Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis, J Orthop Res, 21, 335, 10.1016/S0736-0266(02)00159-6 Eliceiri, 1999, Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability, Mol Cell, 4, 915, 10.1016/S1097-2765(00)80221-X Elsherif, 2004, Dietary copper restriction-induced changes in myocardial gene expression and the effect of copper repletion, Exp Biol Med (Maywood), 229, 616, 10.1177/153537020422900705 Elsherif, 2003, Congestive heart failure in copper-deficient mice, Exp Biol Med (Maywood), 228, 811, 10.1177/15353702-0322807-06 Elsherif, 2004, Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice, J Nutr, 134, 855, 10.1093/jn/134.4.855 Emsley, 1999, Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta, Br J Pharmacol, 126, 1034, 10.1038/sj.bjp.0702374 Engleka, 1992, Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation, J Biol Chem, 267, 11307, 10.1016/S0021-9258(19)49911-0 Fassone, 2011, Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy, J Med Genet, 48, 691, 10.1136/jmedgenet-2011-100340 Feng, 2009, Copper regulation of hypoxia-inducible factor-1 activity, Mol Pharmacol, 75, 174, 10.1124/mol.108.051516 Ferrara, 1999, Role of vascular endothelial growth factor in the regulation of angiogenesis, Kidney Int, 56, 794, 10.1046/j.1523-1755.1999.00610.x Ferrara, 1999, Clinical applications of angiogenic growth factors and their inhibitors, Nat Med, 5, 1359, 10.1038/70928 Ferrara, 1996, Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene, Nature, 380, 439, 10.1038/380439a0 Fiedler, 2002, Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes, Proc Natl Acad Sci U S A, 99, 11363, 10.1073/pnas.162100799 Flesch, 2001, Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading, Circulation, 104, 2273, 10.1161/hc4401.099449 Fong, 1995, Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium, Nature, 376, 66, 10.1038/376066a0 Fong, 1999, Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice, Development, 126, 3015, 10.1242/dev.126.13.3015 Freisinger, 2004, Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper?, J Inherit Metab Dis, 27, 67, 10.1023/B:BOLI.0000016614.47380.2f Frey, 1994, Electron microscopy of cytochrome c oxidase crystals. Monomer–dimer relationship and cytochrome c binding site, J Mol Biol, 237, 275, 10.1006/jmbi.1994.1231 Gale, 1999, Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development, Genes Dev, 13, 1055, 10.1101/gad.13.9.1055 Garnier, 2003, Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles, J Physiol, 551, 491, 10.1113/jphysiol.2003.045104 Gerber, 1999, VEGF is required for growth and survival in neonatal mice, Development, 126, 1149, 10.1242/dev.126.6.1149 Gerhardt, 2003, VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia, J Cell Biol, 161, 1163, 10.1083/jcb.200302047 Ghosh, 2014, Copper supplementation restores cytochrome c oxidase assembly defect in a mitochondrial disease model of COA6 deficiency, Hum Mol Genet, 23, 3596, 10.1093/hmg/ddu069 Gille, 2000, A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration, EMBO J, 19, 4064, 10.1093/emboj/19.15.4064 Glerum, 1996, Characterization of COX17, a yeast gene involved in copper metabolism and assembly of cytochrome oxidase, J Biol Chem, 271, 14504, 10.1074/jbc.271.24.14504 Glerum, 1996, SCO1 and SCO2 act as high copy suppressors of a mitochondrial copper recruitment defect in Saccharomyces cerevisiae, J Biol Chem, 271, 20531, 10.1074/jbc.271.34.20531 Goodman, 2004, Copper deficiency as an anti-cancer strategy, Endocrinol Relat Cancer, 11, 255, 10.1677/erc.0.0110255 Goodman, 1970, Cardiac hypertrophy in rats with iron and copper deficiency: quantitative contribution of mitochondrial enlargement, Pediatr Res, 4, 244, 10.1203/00006450-197005000-00003 Gottlieb, 1994, Reperfusion injury induces apoptosis in rabbit cardiomyocytes, J Clin Invest, 94, 1621, 10.1172/JCI117504 Gupta, 2008, Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB, J Mol Biol, 375, 637, 10.1016/j.jmb.2007.10.006 Haddad, 2005, Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension, ASAIO J, 51, 456, 10.1097/01.mat.0000169125.21268.d7 Hamasaki, 2000, Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy, J Am Coll Cardiol, 35, 1654, 10.1016/S0735-1097(00)00594-5 Hannan, 1982, Modulation of synthesis of specific proteins in endothelial cells by copper, cadmium, and disulfiram: an early response to an angiogenic inducer of cell migration, J Cell Physiol, 111, 207, 10.1002/jcp.1041110213 Hao, 2011, Thioacetamide intoxication triggers transcriptional up-regulation but enzyme inactivation of UDP-glucuronosyltransferases, Drug Metab Dispos, 39, 1815, 10.1124/dmd.111.039172 Harada, 2007, Diacylglycerol kinase zeta attenuates pressure overload-induced cardiac hypertrophy, Circ J, 71, 276, 10.1253/circj.71.276 Harding, 2001, Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure, Circulation, 104, 1241, 10.1161/hc3601.095718 Heerdt, 2000, Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure, Circulation, 102, 2713, 10.1161/01.CIR.102.22.2713 Heineke, 2010, CIB1 is a regulator of pathological cardiac hypertrophy, Nat Med, 16, 872, 10.1038/nm.2181 Heineke, 2006, Regulation of cardiac hypertrophy by intracellular signalling pathways, Nat Rev Mol Cell Biol, 7, 589, 10.1038/nrm1983 Henderson, 1977, Arrangement of cytochrome oxidase molecules in two-dimensional vesicle crystals, J Mol Biol, 112, 631, 10.1016/S0022-2836(77)80167-8 Henry, 2006, Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer, Oncology, 71, 168, 10.1159/000106066 Hershey, 2003, Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits, Heart Vessels, 18, 142, 10.1007/s00380-003-0694-z Hiratsuka, 1998, Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice, Proc Natl Acad Sci, 95, 9349, 10.1073/pnas.95.16.9349 Hirsila, 2005, Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway, FASEB J, 19, 1308, 10.1096/fj.04-3399fje Hoeben, 2004, Vascular endothelial growth factor and angiogenesis, Pharmacol Rev, 56, 549, 10.1124/pr.56.4.3 Holtwick, 2003, Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A, J Clin Invest, 111, 1399, 10.1172/JCI17061 Hon, 2003, Bridge to recovery with the use of left ventricular assist device and clenbuterol, Ann Thorac Surg, 75, S36, 10.1016/S0003-4975(03)00460-0 Horn, 2008, Mitochondrial copper metabolism and delivery to cytochrome c oxidase, IUBMB Life, 60, 421, 10.1002/iub.50 Hou, 2012, Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets, Pharmacol Ther, 135, 337, 10.1016/j.pharmthera.2012.06.006 Hu, 1998, Copper stimulates proliferation of human endothelial cells under culture, J Cell Biochem, 69, 326, 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A Hu, 2007, LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia–reperfusion, Cardiovasc Res, 76, 292, 10.1016/j.cardiores.2007.07.003 Huang, 2010, Targeting the ANGPT–TIE2 pathway in malignancy, Nat Rev Cancer, 10, 575, 10.1038/nrc2894 Huang, 1998, Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin–proteasome pathway, Proc Natl Acad Sci U S A, 95, 7987, 10.1073/pnas.95.14.7987 Hughes, 2008, Role of copper and homocysteine in pressure overload heart failure, Cardiovasc Toxicol, 8, 137, 10.1007/s12012-008-9021-3 Huo, 2007, Capillary perfusion and wall shear stress are restored in the coronary circulation of hypertrophic right ventricle, Circ Res, 100, 273, 10.1161/01.RES.0000257777.83431.13 Ingwall, 2004, Is the failing heart energy starved? On using chemical energy to support cardiac function, Circ Res, 95, 135, 10.1161/01.RES.0000137170.41939.d9 Itoh, 2008, Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation, J Biol Chem, 283, 9157, 10.1074/jbc.M709463200 Ivan, 2001, HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing, Science, 292, 464, 10.1126/science.1059817 Iwai, 1999, Identification of the von Hippel–Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex, Proc Natl Acad Sci U S A, 96, 12436, 10.1073/pnas.96.22.12436 Iwata, 1998, Structure and function of bacterial cytochrome c oxidase, J Biochem, 123, 369, 10.1093/oxfordjournals.jbchem.a021946 Izumiya, 2006, Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload, Hypertension, 47, 887, 10.1161/01.HYP.0000215207.54689.31 Jaakkola, 2001, Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation, Science, 292, 468, 10.1126/science.1059796 Jakobsson, 2010, Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting, Nat Cell Biol, 12, 943, 10.1038/ncb2103 Jaksch, 2001, Homozygosity (E140K) in SCO2 causes delayed infantile onset of cardiomyopathy and neuropathy, Neurology, 57, 1440, 10.1212/WNL.57.8.1440 Jaksch, 2000, Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency, Hum Mol Genet, 9, 795, 10.1093/hmg/9.5.795 Jeansson, 2011, Angiopoietin-1 is essential in mouse vasculature during development and in response to injury, J Clin Invest, 121, 2278, 10.1172/JCI46322 Jeremy, 2002, Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting, Ann Thorac Surg, 74, 1553, 10.1016/S0003-4975(02)03807-9 Jiang, 2007, Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice, J Exp Med, 204, 657, 10.1084/jem.20061943 Jiang, 1997, Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension, J Biol Chem, 272, 19253, 10.1074/jbc.272.31.19253 Johnson, 2006, Cardiac cytochrome-c oxidase deficiency occurs during late postnatal development in progeny of copper-deficient rats, Exp Biol Med (Maywood), 231, 172, 10.1177/153537020623100207 Jullig, 2008, Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats, Proteomics, 8, 2556, 10.1002/pmic.200700977 Kallio, 1998, Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha, EMBO J, 17, 6573, 10.1093/emboj/17.22.6573 Kang, 2011, Copper and homocysteine in cardiovascular diseases, Pharmacol Ther, 129, 321, 10.1016/j.pharmthera.2010.11.004 Kang, 2000, Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart, Proc Soc Exp Biol Med, 223, 282, 10.1046/j.1525-1373.2000.22340.x Karch, 2005, The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy, Cardiovasc Pathol, 14, 135, 10.1016/j.carpath.2005.03.003 Karpanen, 2008, Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy, Circ Res, 103, 1018, 10.1161/CIRCRESAHA.108.178459 Kaza, 2011, Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium, Cardiovasc Res, 89, 410, 10.1093/cvr/cvq321 Ke, 2005, Down-regulation of the expression of the FIH-1 and ARD-1 genes at the transcriptional level by nickel and cobalt in the human lung adenocarcinoma A549 cell line, Int J Environ Res Public Health, 2, 10, 10.3390/ijerph2005010010 Khalimonchuk, 2005, Biogenesis of cytochrome c oxidase, Mitochondrion, 5, 363, 10.1016/j.mito.2005.08.002 Khan, 2002, Radiotherapy and antiangiogenic TM in lung cancer, Neoplasia, 4, 164, 10.1038/sj.neo.7900218 Kim, 2008, Mechanisms for copper acquisition, distribution and regulation, Nat Chem Biol, 4, 176, 10.1038/nchembio.72 Kimball, 1964, Cardiovascular studies on copper-deficient swine. III. Properties of isolated aortic elastin, Exp Mol Pathol, 33, 10, 10.1016/0014-4800(64)90014-0 Kliche, 2001, VEGF receptor signaling and endothelial function, IUBMB Life, 52, 61, 10.1080/15216540252774784 Knowlton, 2014, Heart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategies, J Cardiovasc Pharmacol, 63, 196, 10.1097/01.fjc.0000432861.55968.a6 Kohno, 2013, Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury, Arterioscler Thromb Vasc Biol, 33, 805, 10.1161/ATVBAHA.112.300862 Koitabashi, 2010, Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation. Novel mechanism of cardiac stress modulation by PDE5 inhibition, J Mol Cell Cardiol, 48, 713, 10.1016/j.yjmcc.2009.11.015 Koneru, 2008, Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1, J Cell Mol Med, 12, 2651, 10.1111/j.1582-4934.2008.00319.x Kopp, 1983, Physiological and metabolic characterization of a cardiomyopathy induced by chronic copper deficiency, Am J Physiol, 245, H855 Krick, 2005, Role of hypoxia-inducible factor-1alpha in hypoxia-induced apoptosis of primary alveolar epithelial type II cells, Am J Respir Cell Mol Biol, 32, 395, 10.1165/rcmb.2004-0314OC Krummeck, 1990, Yeast SCO1 protein is required for a post-translational step in the accumulation of mitochondrial cytochrome c oxidase subunits I and II, Curr Genet, 18, 13, 10.1007/BF00321109 Kumar, 2011, Inhibition of nuclear factor kappaB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules, Free Radic Biol Med, 50, 206, 10.1016/j.freeradbiomed.2010.10.711 Lando, 2002, FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor, Genes Dev, 16, 1466, 10.1101/gad.991402 Lando, 2002, Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch, Science, 295, 858, 10.1126/science.1068592 Landriscina, 2001, Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress, J Biol Chem, 276, 25549, 10.1074/jbc.M102925200 Leary, 2007, The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis, Cell Metab, 5, 9, 10.1016/j.cmet.2006.12.001 Leary, 2004, Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase, Hum Mol Genet, 13, 1839, 10.1093/hmg/ddh197 Lee, 1998, Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure, J Thorac Cardiovasc Surg, 116, 344, 10.1016/S0022-5223(98)70136-9 Lee, 2002, Biochemical characterization of the human copper transporter Ctr1, J Biol Chem, 277, 4380, 10.1074/jbc.M104728200 Li, 2011, von Hippel–Lindau protein adjusts oxygen sensing of the FIH asparaginyl hydroxylase, Int J Biochem Cell Biol, 43, 795, 10.1016/j.biocel.2011.02.004 Li, 2014, Copper promotion of angiogenesis in isolated rat aortic ring: role of vascular endothelial growth factor, J Nutr Biochem, 25, 44, 10.1016/j.jnutbio.2013.08.013 Li, 2005, Marginal dietary copper restriction induces cardiomyopathy in rats, J Nutr, 135, 2130, 10.1093/jn/135.9.2130 Li, 2012, Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway, Exp Biol Med (Maywood), 237, 77, 10.1258/ebm.2011.011267 Liebes, 1997, Decreased nuclear encoded subunits of cytochrome c oxidase and increased copper, zinc-superoxide dismutase activity are found in cardiomyopathic human hearts, Int J Cardiol, 62, 259, 10.1016/S0167-5273(97)00254-4 Lin, 1992, Effect of copper ion on collagenase release. Its implication in corneal vascularization, Invest Ophthalmol Vis Sci, 33, 558 Linnebank, 2006, Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells, Neurobiol Dis, 23, 725, 10.1016/j.nbd.2006.06.010 Lu, 2012, LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse, Gene Ther, 19, 522, 10.1038/gt.2011.133 Lucas, 2003, Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy, Am J Physiol Heart Circ Physiol, 284, H575, 10.1152/ajpheart.00619.2002 Luo, 2005, Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy, Mol Cell Biol, 25, 9491, 10.1128/MCB.25.21.9491-9502.2005 Maciag, 1981, Serial propagation of human endothelial cells in vitro, J Cell Biol, 91, 420, 10.1083/jcb.91.2.420 Mahon, 2001, FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity, Genes Dev, 15, 2675, 10.1101/gad.924501 Malinow, 1999, Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association, Circulation, 99, 178, 10.1161/01.CIR.99.1.178 Mann, 1999, Mechanisms and models in heart failure: a combinatorial approach, Circulation, 100, 999, 10.1161/01.CIR.100.9.999 Mansoor, 2000, Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease, Clin Chem, 46, 385, 10.1093/clinchem/46.3.385 Marin-Garcia, 1996, Mitochondrial function in children with idiopathic dilated cardiomyopathy, J Inherit Metab Dis, 19, 309, 10.1007/BF01799259 Marin-Garcia, 2001, Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure, Cardiovasc Res, 52, 103, 10.1016/S0008-6363(01)00368-6 Marin-Garcia, 1995, Impaired mitochondrial function in idiopathic dilated cardiomyopathy: biochemical and molecular analysis, J Card Fail, 1, 285, 10.1016/1071-9164(95)90003-9 Martin, 2005, Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation, Blood, 105, 4613, 10.1182/blood-2004-10-3980 Martins, 1998, Metalloregulation of FRE1 and FRE2 homologs in Saccharomyces cerevisiae, J Biol Chem, 273, 23716, 10.1074/jbc.273.37.23716 Massie, 2002, What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians, J Card Fail, 8, 197, 10.1054/jcaf.2002.127612 Maxwell, 2004, HIF-1: an oxygen and metal responsive transcription factor, Cancer Biol Ther, 3, 29, 10.4161/cbt.3.1.547 McAuslan, 1980, Cellular and molecular mechanisms in angiogenesis, Trans Ophthalmol Soc U K, 100, 354 McAuslan, 1980, Endothelial cell phagokinesis in response to specific metal ions, Exp Cell Res, 130, 147, 10.1016/0014-4827(80)90051-8 McAuslan, 1983, Angiogenic factors and their assay: activity of formyl methionyl leucyl phenylalanine, adenosine diphosphate, heparin, copper, and bovine endothelium stimulating factor, Microvasc Res, 26, 323, 10.1016/0026-2862(83)90080-8 McKie, 2010, The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects, J Am Coll Cardiol, 55, 2140, 10.1016/j.jacc.2010.01.031 McMullen, 2004, Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload, Circulation, 109, 3050, 10.1161/01.CIR.0000130641.08705.45 Meadows, 2001, Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation, J Biol Chem, 276, 49289, 10.1074/jbc.M108069200 Medeiros, 1991, Myofibrillar, mitochondrial and valvular morphological alterations in cardiac hypertrophy among copper-deficient rats, J Nutr, 121, 815, 10.1093/jn/121.6.815 Medeiros, 1993, A unified perspective on copper deficiency and cardiomyopathy, Proc Soc Exp Biol Med, 203, 262, 10.3181/00379727-203-43599 Medeiros, 1991, Copper deficiency in a genetically hypertensive cardiomyopathic rat: electrocardiogram, functional and ultrastructural aspects, J Nutr, 121, 1026, 10.1093/jn/121.7.1026 Medeiros, 1997, Newer findings on a unified perspective of copper restriction and cardiomyopathy, Proc Soc Exp Biol Med, 215, 299, 10.3181/00379727-215-44141 Moriguchi, 2002, The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production, Int J Cancer, 102, 445, 10.1002/ijc.10740 Muller-Hocker, 1986, Fatal mitochondrial cardiomyopathy in Kearns–Sayre syndrome with deficiency of cytochrome-c-oxidase in cardiac and skeletal muscle. An enzymehistochemical–ultra-immunocytochemical–fine structural study in longterm frozen autopsy tissue, Virchows Arch B Cell Pathol Incl Mol Pathol, 52, 353, 10.1007/BF02889977 Nakagami, 2003, A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms, Ann Med, 35, 398, 10.1080/07853890310001294 Narayanan, 2013, CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells, PLoS ONE, 8, e71982, 10.1371/journal.pone.0071982 Neubauer, 2007, The failing heart—an engine out of fuel, N Engl J Med, 356, 1140, 10.1056/NEJMra063052 Nicosia, 1993, Fibronectin promotes the elongation of microvessels during angiogenesis in vitro, J Cell Physiol, 154, 654, 10.1002/jcp.1041540325 Nishio, 1995, Mitochondrial biogenesis during pressure overload induced cardiac hypertrophy in adult rats, Can J Physiol Pharmacol, 73, 630, 10.1139/y95-080 Nittis, 2001, Yeast Sco1, a protein essential for cytochrome c oxidase function is a Cu(I)-binding protein, J Biol Chem, 276, 42520, 10.1074/jbc.M107077200 Nyberg, 2005, Endogenous inhibitors of angiogenesis, Cancer Res, 65, 3967, 10.1158/0008-5472.CAN-04-2427 Obayashi, 1992, Point mutations in mitochondrial DNA in patients with hypertrophic cardiomyopathy, Am Heart J, 124, 1263, 10.1016/0002-8703(92)90410-W O'Halloran, 2000, Metallochaperones, an intracellular shuttle service for metal ions, J Biol Chem, 275, 25057, 10.1074/jbc.R000006200 Okuyama, 2006, Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1, J Biol Chem, 281, 15554, 10.1074/jbc.M602003200 Olivetti, 1997, Apoptosis in the failing human heart, N Engl J Med, 336, 1131, 10.1056/NEJM199704173361603 Olsson, 2006, VEGF receptor signalling — in control of vascular function, Nat Rev Mol Cell Biol, 7, 359, 10.1038/nrm1911 O'Rourke, 1999, Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha, J Biol Chem, 274, 2060, 10.1074/jbc.274.4.2060 Oswald, 2010 Oswald, 2009, Knockdown of human COX17 affects assembly and supramolecular organization of cytochrome c oxidase, J Mol Biol, 389, 470, 10.1016/j.jmb.2009.04.034 Ozaki, 1997, Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates, Exp Eye Res, 64, 505, 10.1006/exer.1996.0239 Pan, 2002, Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis, Cancer Res, 62, 4854 Pandya, 2006, Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo, Proc Natl Acad Sci U S A, 103, 16864, 10.1073/pnas.0607700103 Papadopoulou, 1999, Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene, Nat Genet, 23, 333, 10.1038/15513 Partridge, 2000, Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration, J Cell Biochem, 78, 487, 10.1002/1097-4644(20000901)78:3<487::AID-JCB13>3.0.CO;2-Z Patel, 2001, Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy, Circulation, 104, 317, 10.1161/hc2801.094031 Peichev, 2000, Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors, Blood, 95, 952, 10.1182/blood.V95.3.952.003k27_952_958 Pena, 2000, Characterization of the Saccharomyces cerevisiae high affinity copper transporter Ctr3, J Biol Chem, 275, 33244, 10.1074/jbc.M005392200 Phng, 2009, Angiogenesis: a team effort coordinated by notch, Dev Cell, 16, 196, 10.1016/j.devcel.2009.01.015 Prohaska, 1990, Biochemical changes in copper deficiency, J Nutr Biochem, 1, 452, 10.1016/0955-2863(90)90080-5 Prohaska, 1982, Mechanical properties of the copper-deficient rat heart, J Nutr, 112, 2142 Prudovsky, 2002, The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export, J Cell Biol, 158, 201, 10.1083/jcb.200203084 Qiu, 2012, Copper is required for cobalt-induced transcriptional activity of hypoxia-inducible factor-1, J Pharmacol Exp Ther, 342, 561, 10.1124/jpet.112.194662 Quigley, 2000, Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy, J Card Fail, 6, 47, 10.1016/S1071-9164(00)00011-7 Radford, 2002, Cardiac dysfunction in mice lacking cytochrome-c oxidase subunit VIaH, Am J Physiol Heart Circ Physiol, 282, H726, 10.1152/ajpheart.00308.2001 Rahimi, 2000, Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells, J Biol Chem, 275, 16986, 10.1074/jbc.M000528200 Raju, 1982, Ceruloplasmin, copper ions, and angiogenesis, J Natl Cancer Inst, 69, 1183 Redman, 2003, Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer, Clin Cancer Res, 9, 1666 Reiser, 1985, Indices of copper status in humans consuming a typical American diet containing either fructose or starch, Am J Clin Nutr, 42, 242, 10.1093/ajcn/42.2.242 Robinson, 2010, Copper metallochaperones, Annu Rev Biochem, 79, 537, 10.1146/annurev-biochem-030409-143539 Roguin, 2003, Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model, Cardiovasc Diabetol, 2, 18, 10.1186/1475-2840-2-18 Rosca, 2008, Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation, Cardiovasc Res, 80, 30, 10.1093/cvr/cvn184 Sadoshima, 1995, Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy, Circ Res, 77, 1040, 10.1161/01.RES.77.6.1040 Saito, 2010, Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist, J Heart Lung Transplant, 29, 672, 10.1016/j.healun.2010.01.007 Salceda, 1997, Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin–proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes, J Biol Chem, 272, 22642, 10.1074/jbc.272.36.22642 Salzberg, 2003, Quality requirements in clinical studies: a necessary burden?, Swiss Med Wkly, 133, 429 Sano, 2007, p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload, Nature, 446, 444, 10.1038/nature05602 Saraste, 1990, Structural features of cytochrome oxidase, Q Rev Biophys, 23, 331, 10.1017/S0033583500005588 Sartoretto, 2009, Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart, Am J Physiol Heart Circ Physiol, 297, H1697, 10.1152/ajpheart.00595.2009 Schmidt, 1989 Schofield, 1999, Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes, Curr Opin Struct Biol, 9, 722, 10.1016/S0959-440X(99)00036-6 Schulze, 1988, SCO1, a yeast nuclear gene essential for accumulation of mitochondrial cytochrome c oxidase subunit II, Mol Gen Genet, 211, 492, 10.1007/BF00425706 Schwarz, 2014, The breathing heart — mitochondrial respiratory chain dysfunction in cardiac disease, Int J Cardiol, 171, 134, 10.1016/j.ijcard.2013.12.014 Seetharam, 1995, A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF, Oncogene, 10, 135 Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat Rev Cancer, 3, 721, 10.1038/nrc1187 Semenza, 1996, Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1, J Biol Chem, 271, 32529, 10.1074/jbc.271.51.32529 Semenza, 2007, HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia, Antioxid Redox Signal, 9, 1391, 10.1089/ars.2007.1691 Sen, 2002, Copper-induced vascular endothelial growth factor expression and wound healing, Am J Physiol Heart Circ Physiol, 282, H1821, 10.1152/ajpheart.01015.2001 Sharov, 2000, Abnormal mitochondrial respiration in failed human myocardium, J Mol Cell Cardiol, 32, 2361, 10.1006/jmcc.2000.1266 Shields, 1962, Studies on copper metabolism. 32. Cardiovascular lesions in copper-deficient swine, Am J Pathol, 41, 603 Shimojo, 2007, Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy, Am J Physiol Heart Circ Physiol, 293, H474, 10.1152/ajpheart.00922.2006 Shing, 1984, Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor, Science, 223, 1296, 10.1126/science.6199844 Shioi, 2002, Akt/protein kinase B promotes organ growth in transgenic mice, Mol Cell Biol, 22, 2799, 10.1128/MCB.22.8.2799-2809.2002 Shioi, 2003, Rapamycin attenuates load-induced cardiac hypertrophy in mice, Circulation, 107, 1664, 10.1161/01.CIR.0000057979.36322.88 Shiojima, 2005, Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure, J Clin Invest, 115, 2108, 10.1172/JCI24682 Shiraishi, 2004, Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes, Circ Res, 94, 884, 10.1161/01.RES.0000124394.01180.BE Shu, 2002, Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases, Mol Cell Biol, 22, 7758, 10.1128/MCB.22.22.7758-7768.2002 Shukla, 2007, Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein, Ann Thorac Surg, 84, 43, 10.1016/j.athoracsur.2007.03.087 Shyu, 2005, Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart, 12 Shyu, 2005, Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in pressure-overloaded rat heart, J Biomed Sci, 12, 409, 10.1007/s11373-005-3008-x Silvestre, 2003, Vascular endothelial growth factor-B promotes in vivo angiogenesis, Circ Res, 93, 114, 10.1161/01.RES.0000081594.21764.44 Skurk, 2005, The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling, J Biol Chem, 280, 20814, 10.1074/jbc.M500528200 Soncin, 1997, Interaction of human angiopoietin with copper modulates angiopoietin binding to endothelial cells, Biochem Biophys Res Commun, 236, 604, 10.1006/bbrc.1997.7018 Song, 2007, VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes, Biochem Biophys Res Commun, 354, 999, 10.1016/j.bbrc.2007.01.095 Stewart, 2009, VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial, Mol Ther, 17, 1109, 10.1038/mt.2009.70 Strilic, 2009, The molecular basis of vascular lumen formation in the developing mouse aorta, Dev Cell, 17, 505, 10.1016/j.devcel.2009.08.011 Sturtz, 2001, A fraction of yeast Cu, Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage, J Biol Chem, 276, 38084, 10.1074/jbc.M105296200 Subramanian, 2014, Differential metal content and gene expression in rat left ventricular hypertrophy due to hypertension and hyperactivity, J Trace Elem Med Biol, 28, 311, 10.1016/j.jtemb.2014.02.002 Sun, 2014, Vascular endothelial growth factor recovers suppressed cytochrome c oxidase activity by restoring copper availability in hypertrophic cardiomyocytes, Exp Biol Med (Maywood), 10.1007/978-94-017-9487-9 Suri, 1998, Increased vascularization in mice overexpressing angiopoietin-1, Science, 282, 468, 10.1126/science.282.5388.468 Takahashi, 1999, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat Med, 5, 434, 10.1038/8462 Takahashi, 1999, Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes, Circ Res, 84, 1194, 10.1161/01.RES.84.10.1194 Takahashi, 1999, VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells, Oncogene, 18, 2221, 10.1038/sj.onc.1202527 Takemura, 2013, Cardiomyocyte apoptosis in the failing heart—a critical review from definition and classification of cell death, Int J Cardiol, 167, 2373, 10.1016/j.ijcard.2013.01.163 Takimoto, 2005, Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy, Nat Med, 11, 214, 10.1038/nm1175 Tang, 2003, Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure, Nat Med, 9, 1506, 10.1038/nm958 Tardiff, 2000, Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects, Am J Physiol Heart Circ Physiol, 278, H412, 10.1152/ajpheart.2000.278.2.H412 Tolentino, 1996, Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate, Ophthalmology, 103, 1820, 10.1016/S0161-6420(96)30420-X Trumbo, 2001, Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc, J Am Diet Assoc, 101, 294, 10.1016/S0002-8223(01)00078-5 Tsen, 2003, Homocysteine altered ROS generation and NO accumulation in endothelial cells, Chin J Physiol, 46, 129 Tsukihara, 1995, Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 2.8A, Science, 269, 1069, 10.1126/science.7652554 Tsukihara, 1996, The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8A, Science, 272, 1136, 10.1126/science.272.5265.1136 Ulyatt, 2011, Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells, Biochem Biophys Res Commun, 404, 774, 10.1016/j.bbrc.2010.12.057 van Bilsen, 2004, Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?, Cardiovasc Res, 61, 218, 10.1016/j.cardiores.2003.11.014 van Heerden, 2004, Effects of short-term copper exposure on gill structure, metallothionein and hypoxia-inducible factor-1alpha (HIF-1alpha) levels in rainbow trout (Oncorhynchus mykiss), Aquat Toxicol, 69, 271, 10.1016/j.aquatox.2004.06.002 Viestenz, 1982, A randomized trial of copper therapy in rats with electrocardiographic abnormalities due to copper deficiency, Am J Clin Nutr, 35, 258, 10.1093/ajcn/35.2.258 Waltenberger, 1994, Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor, J Biol Chem, 269, 26988, 10.1016/S0021-9258(18)47116-5 Wang, 2013, Copper chaperone for superoxide dismutase-1 transfers copper to mitochondria but does not affect cytochrome c oxidase activity, Exp Biol Med (Maywood), 238, 1017, 10.1177/1535370213497327 Wang, 2014, Brief communication: copper suppression of vascular endothelial growth factor receptor-2 is involved in the regression of cardiomyocyte hypertrophy, Exp Biol Med (Maywood), 239, 948, 10.1177/1535370214536119 Wang, 1993, Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia, J Biol Chem, 268, 21513, 10.1016/S0021-9258(20)80571-7 Wang, 1993, Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction, Blood, 82, 3610, 10.1182/blood.V82.12.3610.3610 Wang, 1993, General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia, Proc Natl Acad Sci U S A, 90, 4304, 10.1073/pnas.90.9.4304 Wang, 1995, Purification and characterization of hypoxia-inducible factor 1, J Biol Chem, 270, 1230, 10.1074/jbc.270.3.1230 Wang, 1996, Molecular basis of hypoxia-induced erythropoietin expression, Curr Opin Hematol, 3, 156, 10.1097/00062752-199603020-00009 Wanner, 2000, Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation, Blood, 96, 1558, 10.1182/blood.V96.4.1558 Warren, 2010, Signaling circuitry in vascular morphogenesis, Curr Opin Hematol, 17, 213 Weissman, 1963, Cardiovascular studies on copper-deficient swine. IV. Content and solubility of the aortic elastin, collagen, and hexosamine, J Biol Chem, 238, 3115, 10.1016/S0021-9258(18)51876-7 Wenger, 2000, Mammalian oxygen sensing, signalling and gene regulation, J Exp Biol, 203, 1253, 10.1242/jeb.203.8.1253 Wikman-Coffelt, 1979, The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development, Circ Res, 45, 697, 10.1161/01.RES.45.6.697 Wildman, 1995, Marginal copper-restricted diets produce altered cardiac ultrastructure in the rat, Proc Soc Exp Biol Med, 210, 43, 10.3181/00379727-210-43923 Witte, 2005, The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure, Eur Heart J, 26, 2238, 10.1093/eurheartj/ehi442 Wollert, 2002, Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes, Hypertension, 39, 87, 10.1161/hy1201.097292 Wu, 2009, Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction, Am J Physiol Cell Physiol, 297, C928, 10.1152/ajpcell.00045.2009 Yang, 2007, 1-Methylhydantoin cytotoxicity on renal proximal tubular cells in vitro, Ren Fail, 29, 1025, 10.1080/08860220701641272 Yoshida, 1995, Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion, Neurol Med Chir (Tokyo), 35, 133, 10.2176/nmc.35.133 Yoshii, 2001, The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells, Int J Cancer, 94, 768, 10.1002/ijc.1537 Zafeiridis, 1998, Regression of cellular hypertrophy after left ventricular assist device support, Circulation, 98, 656, 10.1161/01.CIR.98.7.656 Zeeb, 2010, Resolving cell–cell junctions: lumen formation in blood vessels, Curr Opin Cell Biol, 22, 626, 10.1016/j.ceb.2010.07.003 Zeng, 2001, Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways, J Biol Chem, 276, 26969, 10.1074/jbc.M103213200 Zentilin, 2010, Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction, FASEB J, 24, 1467, 10.1096/fj.09-143180 Zeviani, 1986, Myopathy and fatal cardiopathy due to cytochrome c oxidase deficiency, Arch Neurol, 43, 1198, 10.1001/archneur.1986.00520110084025 Zhang, 2014, Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation, Cardiovasc Diabetol, 13, 100, 10.1186/1475-2840-13-100 Zhang, 2010, VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2, Cell Death Differ, 17, 499, 10.1038/cdd.2009.152 Zhang, 2014, Copper-dependent and -independent hypoxia-inducible factor-1 regulation of gene expression, Metallomics, 10.1039/C4MT00052H Zhang, 2013, Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats, Cardiovasc Diabetol, 12, 123, 10.1186/1475-2840-12-123 Zhou, 2009, Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway, Cardiovasc Res, 84, 54, 10.1093/cvr/cvp178 Zhou, 2007, Copper inhibition of hydrogen peroxide-induced hypertrophy in embryonic rat cardiac H9c2 cells, Exp Biol Med (Maywood), 232, 385 Zhou, 2008, Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size, J Mol Cell Cardiol, 45, 106, 10.1016/j.yjmcc.2008.03.022 Ziche, 1982, Role of prostaglandin E1 and copper in angiogenesis, J Natl Cancer Inst, 69, 475 Zisa, 2009, Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells, Am J Physiol Regul Integr Comp Physiol, 297, R1503, 10.1152/ajpregu.00227.2009 Zuo, 2013, Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes, PLoS ONE, 8, e67549, 10.1371/journal.pone.0067549 Zuo, 2010, Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy, Cardiovasc Toxicol, 10, 208, 10.1007/s12012-010-9080-0